Elite Pharmaceuticals, Inc. Derivative Liability, Fair Value, Amount Not Offset Against Collateral
Elite Pharmaceuticals, Inc. (ELTP) had Derivative Liability, Fair Value, Amount Not Offset Against Collateral of $35.00 million as of 2015-03-31, per its 10-K filed 2015-06-15.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral · last filed 2015-06-15
- 2015-03-31: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $35.00M.
- 2014-03-31: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $60.98M.
- 2013-12-31: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $19.82K.
- 2013-09-30: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $203.01K.
| Period end | Derivative Liability, Fair Value, Amount Not Offset Against Collateral |
|---|---|
| 2015-03-31 | $35.00M 10-K · filed 2015-06-15 |
| 2014-03-31 | $60.98M 10-K · filed 2015-06-15 |
| 2013-12-31 | $19.82K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $203.01K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $6.27M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $6.33M 10-K · filed 2014-06-30 |